Cumberland Pharmaceuticals Inc Stock Ownership - Who owns Cumberland Pharmaceuticals?

Insider buying vs selling

Have Cumberland Pharmaceuticals Inc insiders been buying or selling?
James JonesDirector2024-03-251,000$1.71
Kenneth KrogulskiDirector2024-03-255,000$1.71
Joseph C. GalanteDirector2024-03-251,000$1.71
Caroline YoungDirector2024-03-251,000$1.71
Martin S. Brown Jr.Director2024-03-251,000$1.71
John M. HammVP Chief Financial Officer2024-03-23445$1.81
James L. HermanVP and Chief Compliance Office2024-03-231,186$1.81
A. J. KazimiChairman and CEO2024-03-2325,710$1.81
Todd M. AnthonyVice Pres Organizational Dev2024-03-23816$1.81
Chris T. BittermanVice Pres Sales Marketing2024-03-23593$1.81

1 of 37

CPIX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CPIX insiders and whales buy or sell their stock.

CPIX Shareholders

What type of owners hold Cumberland Pharmaceuticals Inc stock?
A. J. Kazimi40.13%5,695,557$8.60MInsider
Lawrence W. Greer4.11%583,344$880.85kInsider
Renaissance Technologies LLC3.82%542,663$819.42kInstitution
Jean W. Marstiller3.11%440,828$665.65kInsider
Robert Edwards2.94%417,569$630.53kInsider
Vanguard Group Inc2.64%374,251$565.12kInstitution
Dimensional Fund Advisors LP2.52%357,615$540.00kInstitution
Bridgeway Capital Management LLC2.02%286,655$432.85kInstitution
Kenneth Krogulski1.70%241,277$364.33kInsider
Thomas R. Lawrence1.44%204,110$308.21kInsider

1 of 3

CPIX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CPIX15.24%58.39%Net BuyingNet Selling
TXMD3.69%96.31%Net Buying
KALA1.24%98.76%Net SellingNet Selling
TLPH9.46%90.54%Net BuyingNet Buying

Cumberland Pharmaceuticals Stock Ownership FAQ

Who owns Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals (NASDAQ: CPIX) is owned by 15.24% institutional shareholders, 58.39% Cumberland Pharmaceuticals insiders, and 26.37% retail investors. A. J. Kazimi is the largest individual Cumberland Pharmaceuticals shareholder, owning 5.70M shares representing 40.13% of the company. A. J. Kazimi's Cumberland Pharmaceuticals shares are currently valued at $8.83M.

If you're new to stock investing, here's how to buy Cumberland Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.